For Research Use Only. Not for human or veterinary use.
EPO is listed for legitimate laboratory and research procurement. This 99%+ research-use product is available in 1 listed specification. Review product codes, storage guidance and COA status, then request a wholesale quotation. Batch documentation is available on request.
Volume discounts are available for larger purchasing plans. Please contact us for a quotation.
Delivery includedUsually within 7 days after dispatch
Quality resolutionRefund or replacement when approved
24/7 contactWholesale assistance on WhatsApp
Product profile
About EPO
"Erythropoietin (EPO) is an endogenous glycoprotein hormone composed of 165 amino acids. In adults, 80-90% is synthesized by peritubular interstitial cells in the renal cortex; in fetuses, the liver is the primary production site. Its core physiological function is to stimulate the proliferation and differentiation of erythroid progenitor cells in the bone marrow, ultimately producing mature red blood cells, thereby increasing the blood's oxygen-carrying capacity.
The widely used clinical formulations are recombinant human erythropoietin (rhEPO), produced via recombinant DNA technology, for treating anemia caused by renal failure, chemotherapy, and other conditions."
Main functions
"1.Treats Renal Anemia: Used for anemia associated with chronic kidney disease (including dialysis and non-dialysis patients)—this is its core clinical application.
2.Treats Chemotherapy-Induced Anemia: Indicated for certain cancer patients with chemotherapy-induced anemia to reduce transfusion requirements.
3.Other Anemias: Also used for zidovudine-induced anemia in HIV patients, to promote hematopoiesis after bone marrow transplantation, and for autologous blood transfusion preparation in elective surgery patients.
4.Investigational Neuroprotection: Recent meta-analyses suggest that EPO may reduce short- and mid-term mortality in traumatic brain injury (TBI) patients due to anti-apoptotic, anti-inflammatory, and neurogenic properties, though it does not significantly improve good neurological recovery."
Recommended audience
"Patients with chronic kidney disease (CKD) and anemia.
Patients with chemotherapy-induced anemia from cancer treatment.
HIV patients with anemia following antiretroviral therapy (e.g., zidovudine).
Specific populations in clinical research (e.g., TBI patients in intensive care)."
Order formatOne box accepted
QuotationConfirmed on WhatsApp
DeliveryShipping and duties included
DocumentationPublished COA or available on request
Research product specification
Product information
EPO is listed for legitimate laboratory and research procurement. This 99%+ research-use product is available in 1 listed specification. Review product codes, storage guidance and COA status, then request a wholesale quotation. Batch documentation is available on request.
Handling information
Storage guidance
Keep unopened lyophilized products protected from light and moisture; store at 2-8°C short term or -20°C long term. After reconstitution, refrigerate according to product documentation and minimize freeze-thaw cycles.
Customer-first resolution
Report quality concerns within 14 days of delivery
Contact us with the order number, batch details and available photos. Opened products are accepted for review. When a quality claim is approved, you may choose a full refund or replacement shipment.
